- Home
- SNTI vs SCWO Comparison
SNTI vs SCWO Comparison
Compare SNTI & SCWO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTI
- SCWO
- Stock Information
- Founded
- SNTI 2016
- SCWO 2021
- Country
- SNTI United States
- SCWO United States
- Employees
- SNTI N/A
- SCWO N/A
- Industry
- SNTI Biotechnology: Pharmaceutical Preparations
- SCWO Environmental Services
- Sector
- SNTI Health Care
- SCWO Utilities
- Exchange
- SNTI Nasdaq
- SCWO Nasdaq
- Market Cap
- SNTI 39.6M
- SCWO 35.5M
- IPO Year
- SNTI N/A
- SCWO N/A
- Fundamental
- Price
- SNTI $1.56
- SCWO $0.30
- Analyst Decision
- SNTI Strong Buy
- SCWO
- Analyst Count
- SNTI 2
- SCWO 0
- Target Price
- SNTI $8.50
- SCWO N/A
- AVG Volume (30 Days)
- SNTI 107.2K
- SCWO 1.4M
- Earning Date
- SNTI 08-07-2025
- SCWO 08-12-2025
- Dividend Yield
- SNTI N/A
- SCWO N/A
- EPS Growth
- SNTI N/A
- SCWO N/A
- EPS
- SNTI N/A
- SCWO N/A
- Revenue
- SNTI N/A
- SCWO $1,231,413.00
- Revenue This Year
- SNTI N/A
- SCWO $5,945.19
- Revenue Next Year
- SNTI $150.00
- SCWO $106.82
- P/E Ratio
- SNTI N/A
- SCWO N/A
- Revenue Growth
- SNTI N/A
- SCWO 403.17
- 52 Week Low
- SNTI $1.46
- SCWO $0.16
- 52 Week High
- SNTI $16.94
- SCWO $1.99
- Technical
- Relative Strength Index (RSI)
- SNTI 37.24
- SCWO 64.09
- Support Level
- SNTI $1.52
- SCWO $0.22
- Resistance Level
- SNTI $1.65
- SCWO $0.36
- Average True Range (ATR)
- SNTI 0.10
- SCWO 0.03
- MACD
- SNTI 0.03
- SCWO 0.01
- Stochastic Oscillator
- SNTI 50.00
- SCWO 57.14
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
About SCWO 374Water Inc.
374Water Inc offers a technology that transforms wet wastes such as sewage sludge, biosolids, food waste, hazardous and non-hazardous waste, and forever chemicals (e.g., PFAS) into recoverable resources by focusing on waste as a valuable resource for water, energy, and minerals. The company's business activities include manufacturing processes and waste recycling and treatment processes, which currently involve the use, treatment, storage, transfer, handling and/or disposal of hazardous materials, chemicals and wastes.